Current Atherosclerosis Reports

, Volume 14, Issue 4, pp 373–381

Intracranial Hemorrhage in Patients with Cancer

  • Alan J. Velander
  • Lisa M. DeAngelis
  • Babak B. Navi
Cardiovascular Disease and Stroke (M Fink and J Safdieh, Section Editors)


Intracranial hemorrhage (ICH) is a common neurological emergency in patients with cancer, typically occurring late in the disease course, although it occasionally heralds the cancer diagnosis. ICH in these patients often occurs from unique mechanisms, especially intratumoral hemorrhage or coagulopathy, whereas hypertensive hemorrhage is rare. Lung, melanoma, breast, and glioblastoma multiforme are the most commonly associated solid tumors, partly because of their ubiquity and frequent brain involvement, whereas leukemia is the most commonly associated hematological cancer. Patients typically present with focal neurological deficits, headache, and encephalopathy, and their initial diagnostic evaluation and management should follow standard guidelines, although steroids and/or surgical resection should be strongly considered in those with intratumoral hemorrhage. Short-term outcomes are comparable to ICH in the community, whereas long-term outcomes are generally poor, corresponding to the prognosis of the underlying cancer. This review focuses on the recent advances and special considerations in cancer-related intracranial hemorrhage.


Cancer Malignancy Neoplasm Intracranial hemorrhage Hemorrhagic stroke Intracerebral hemorrhage Subarachnoid hemorrhage 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985;64:16–35.PubMedCrossRefGoogle Scholar
  3. 3.
    McCormick WF, Rosenfield DB. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke. 1973;4:946–54.PubMedCrossRefGoogle Scholar
  4. 4.
    Licata B, Turazzi S. Bleeding cerebral neoplasms with symptomatic hematoma. J Neurosurg Sci. 2003;47:201–10.PubMedGoogle Scholar
  5. 5.
    •• Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010;74:494–501. This is a large modern series from the Memorial Sloan-Kettering Cancer Center of intracerebral and subarachnoid hemorrhage in patients with cancer (including systemic and primary brain neoplasms). This study details the demographics, presentation, pathophysiology, and outcome of patients with cancer and intracerebral and/or subarachnoid hemorrhage. PubMedCrossRefGoogle Scholar
  6. 6.
    Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin. 2003;21:167–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Minette SE, Kimmel DW. Subdural hematoma in patients with systemic cancer. Mayo Clin Proc. 1989;64:637–42.PubMedGoogle Scholar
  8. 8.
    Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol. 2005;75:57–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Simmons NE, Elias WJ, Henson SL, Laws ER. Small cell lung carcinoma causing epidural hematoma: case report. Surg Neurol. 1999;51:56–69.PubMedCrossRefGoogle Scholar
  10. 10.
    Navi BB, Segal AZ. Cancer and stroke. In: Geyer JD, Gomez CR, editors. Stroke: a practical approach. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 48–55.Google Scholar
  11. 11.
    Weisberg LA. Computerized tomography in intracranial hemorrhage. Arch Neurol. 1979;36:422–6.PubMedCrossRefGoogle Scholar
  12. 12.
    • Kamel H, Navi BB, Hemphill JC. A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care. 2011;1–5. This is a retrospective study of the yield of MRI for underlying lesions in patients with spontaneous intracerebral hemorrhage, suggesting that the yield can be stratified by clinical characteristics, such as age, history of hypertension, and a lobar location. Google Scholar
  13. 13.
    Kothbauer P, Jellinger K, Falment H. Primary brain tumour presenting as spontaneous intracerebral haemorrhage. Acta Neurochir (Wien). 1979;49:35–45.CrossRefGoogle Scholar
  14. 14.
    Schrader B, Barth H, Lang EW, et al. Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien). 2000;142:979–85.CrossRefGoogle Scholar
  15. 15.
    Abrahams NA, Prayson RA. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: a clinical pathologic analysis of 31 cases. Ann Diagn Pathol. 2000;4:361–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Scott M. Spontaneous intracerebral hematoma caused by cerebral neoplasms. Report of eight verified cases. J Neurosurg. 1975;42:338–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Jellinger K. Pathology of intracerebral hemorrhage. Zentralbl Neurochir. 1977;38:29–42.PubMedGoogle Scholar
  18. 18.
    Kondziolka D, Bernstein M, Resch L, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67:852–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Lieu AS, Hwang SL, Howng SL, Chai CY. Brain tumors with hemorrhage. J Formos Med Assoc. 1999;98:365–7.PubMedGoogle Scholar
  20. 20.
    van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.PubMedCrossRefGoogle Scholar
  21. 21.
    Liu Y, Liu M, Zhu S, et al. Intracranial tumoural haemorrhage-a report of 58 cases. J Clin Neurosci. 2002;9:637–9.CrossRefGoogle Scholar
  22. 22.
    Liwnicz BH, Wu SZ, Tew JM. The relationship between the capillary structure and hemorrhage in gliomas. J Neurosurg. 1987;66:536–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698–705.PubMedCrossRefGoogle Scholar
  24. 24.
    Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Chang L, Chen Y-LL, Kao M-CC. Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol. 2004;62:172–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Oka K, Tsuda H, Sakamoto S, Go Y, et al. Plasminogen activator and hemorrhage in brain tumors. J Neurooncol. 1994;22:183–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Shin J, Moon K-SS, Jung T-YY, et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76:257–63.CrossRefGoogle Scholar
  29. 29.
    Wakai S, Yamakawa K, Manaka S, et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10:437–44.PubMedCrossRefGoogle Scholar
  30. 30.
    Openshaw H, Ressler JA, Snyder DS. Lumbar puncture and subdural hygroma and hematomas in hematopoietic cell transplant patients. Bone Marrow Transplant. 2008;41:791–5.PubMedCrossRefGoogle Scholar
  31. 31.
    McIver JI, Scheithauer BW, Rydberg CH, et al. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report. Neurosurgery. 2001;49:447–9.PubMedGoogle Scholar
  32. 32.
    Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257–62.PubMedCrossRefGoogle Scholar
  33. 33.
    Atlas SW, Grossman RI, Gomori JM, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology. 1987;164:71–7.PubMedGoogle Scholar
  34. 34.
    Tung GA, Julius BD, Rogg JM. MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause. Neuroradiology. 2003;45:357–62.PubMedCrossRefGoogle Scholar
  35. 35.
    Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.PubMedCrossRefGoogle Scholar
  36. 36.
    Brain Trauma Foundation. Guidelines for the surgical management of traumatic brain injury. Neurosurgery. 2006;58 Suppl 2.Google Scholar
  37. 37.
    Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500.PubMedCrossRefGoogle Scholar
  38. 38.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedGoogle Scholar
  39. 39.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.PubMedCrossRefGoogle Scholar
  40. 40.
    Golash A, Thorne J, West CG. Low grade pilocytic astrocytoma presenting as a spontaneous intracerebral haemorrhage in a child. Br J Neurosurg. 1998;12:59–62.PubMedCrossRefGoogle Scholar
  41. 41.
    Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Report Med. 2011;1–3.Google Scholar
  42. 42.
    • Masrur S, Abdullah AR, Smith EE, et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis. 2011;20:124–130. This is the largest clinical series (n = 18) of thrombolytic therapy for acute ischemic stroke in patients with cancer. The rate of symptomatic intracranial hemorrhage in these patients was reasonable (5.6 %), suggesting that thrombolysis may be safe in patients with malignancy. PubMedCrossRefGoogle Scholar
  43. 43.
    Graber JJ, Nayak L, DeAngelis LM. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. J Neurooncol. 2012;In press.Google Scholar
  44. 44.
    Schiff D, DeAngelis LM. Therapy of venous thromboembolism in patients with brain metastases. Cancer. 1994;73:493–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Nghiemphu PL, Green RM, Pope WB, et al. Safety of anticoagulation use and bevacizumab in patients with glioma. Neuro Oncol. 2008;10:355–60.PubMedCrossRefGoogle Scholar
  46. 46.
    • Khasraw M, Holodny A, Goldlust SA, DeAngelis LM: Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Ann Oncol 2011. This is a Retrospective analysis of 4191 patients with cancer who received bevacizumab at the Memorial Sloan-Kettering Cancer Center. In this study, intracranial hemorrhage in these patients was rare and prior bevacizumab therapy was not associated with an increased rate. Google Scholar
  47. 47.
    Novello S, Camps C, Grossi F, et al. Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases. J Thorac Oncol. 2011;6:1260–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Anderson WS, Moore LE, Ford E, Rigamonti D. Fatal case of intracerebral hemorrhage during gamma knife treatment for metastases. Clin Neurol Neurosurg. 2008;110:838–42.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Alan J. Velander
    • 1
  • Lisa M. DeAngelis
    • 2
  • Babak B. Navi
    • 3
  1. 1.Division of Stroke and Critical Care, Department of Neurology and NeuroscienceNew York-Presbyterian Hospital/Columbia and Cornell Medical CentersNew YorkUSA
  2. 2.Department of NeurologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Division of Stroke and Critical Care, Department of Neurology and NeuroscienceWeill Cornell Medical CollegeNew YorkUSA

Personalised recommendations